Literature DB >> 22965740

Evaluation of genes involved in limb development, angiogenesis, and coagulation as risk factors for congenital limb deficiencies.

Marilyn L Browne1, Tonia C Carter, Denise M Kay, Devon Kuehn, Lawrence C Brody, Paul A Romitti, Aiyi Liu, Michele Caggana, Charlotte M Druschel, James L Mills.   

Abstract

We conducted a population-based case-control study of single nucleotide polymorphisms (SNPs) in selected genes to find common variants that play a role in the etiology of limb deficiencies (LDs). Included in the study were 389 infants with LDs of unknown cause and 980 unaffected controls selected from all births in New York State (NYS) for the years 1998-2005. We used cases identified from the NYS Department of Health (DOH) Congenital Malformations Registry. Genotypes were obtained for 132 SNPs in genes involved in limb development (SHH, WNT7A, FGF4, FGF8, FGF10, TBX3, TBX5, SALL4, GREM1, GDF5, CTNNB1, EN1, CYP26A1, CYP26B1), angiogenesis (VEGFA, HIF1A, NOS3), and coagulation (F2, F5, MTHFR). Genotype call rates were >97% and SNPs were tested for departure from Hardy-Weinberg expectations by race/ethnic subgroups. For each SNP, odds ratios (OR)s and confidence intervals (CI)s were estimated and corrected for multiple comparisons for all LDs combined and for LD subtypes. Among non-Hispanic white infants, associations between FGF10 SNPs rs10805683 and rs13170645 and all LDs combined were statistically significant following correction for multiple testing (OR = 1.99; 95% CI = 1.43-2.77; uncorrected P = 0.000043 for rs10805683 heterozygous genotype, and OR = 2.37; 95% CI = 1.48-3.78; uncorrected P = 0.00032 for rs13170645 homozygous minor genotype). We also observed suggestive evidence for associations with SNPs in other genes including CYP26B1 and WNT7A. Animal studies have shown that FGF10 induces formation of the apical ectodermal ridge and is necessary for limb development. Our data suggest that common variants in FGF10 increase the risk for a wide range of non-syndromic limb deficiencies.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22965740      PMCID: PMC3448837          DOI: 10.1002/ajmg.a.35565

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  21 in total

1.  The teratogenicity of N(omega)-nitro-L-ariginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, in rats.

Authors:  A G Fantel; N Nekahi; T H Shepard; L M Cornel; A S Unis; R J Lemire
Journal:  Reprod Toxicol       Date:  1997 Sep-Oct       Impact factor: 3.143

2.  An evaluation of congenital malformations surveillance in New York State: an application of Centers for Disease Control and Prevention (CDC) guidelines for evaluating surveillance systems.

Authors:  J P Sekhobo; C M Druschel
Journal:  Public Health Rep       Date:  2001 Jul-Aug       Impact factor: 2.792

3.  Folate and vitamin B12-related genes and risk for omphalocele.

Authors:  James L Mills; Tonia C Carter; Denise M Kay; Marilyn L Browne; Lawrence C Brody; Aiyi Liu; Paul A Romitti; Michele Caggana; Charlotte M Druschel
Journal:  Hum Genet       Date:  2011-11-25       Impact factor: 4.132

4.  Mutations in WNT7A cause a range of limb malformations, including Fuhrmann syndrome and Al-Awadi/Raas-Rothschild/Schinzel phocomelia syndrome.

Authors:  C G Woods; S Stricker; P Seemann; R Stern; J Cox; E Sherridan; E Roberts; K Springell; S Scott; G Karbani; S M Sharif; C Toomes; J Bond; D Kumar; L Al-Gazali; S Mundlos
Journal:  Am J Hum Genet       Date:  2006-06-23       Impact factor: 11.025

5.  Risks of human limb deficiency anomalies associated with 29 SNPs of genes involved in homocysteine metabolism, coagulation, cell-cell interactions, inflammatory response, and blood pressure regulation.

Authors:  Suzan L Carmichael; Gary M Shaw; David M Iovannisci; Wei Yang; Richard H Finnell; Suzanne Cheng; Edward J Lammer
Journal:  Am J Med Genet A       Date:  2006-11-15       Impact factor: 2.802

6.  A pilot study of the possible role of familial defects in anticoagulation as a cause for terminal limb reduction malformations.

Authors:  A G Hunter
Journal:  Clin Genet       Date:  2000-03       Impact factor: 4.438

Review 7.  The role of CYP26 enzymes in defining appropriate retinoic acid exposure during embryogenesis.

Authors:  Tracie Pennimpede; Don A Cameron; Glenn A MacLean; Hui Li; Suzan Abu-Abed; Martin Petkovich
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-10

8.  Risk of limb deficiency defects associated with NAT1, NAT2, GSTT1, GSTM1, and NOS3 genetic variants, maternal smoking, and vitamin supplement intake.

Authors:  Suzan L Carmichael; Gary M Shaw; Wei Yang; David M Iovannisci; Edward Lammer
Journal:  Am J Med Genet A       Date:  2006-09-15       Impact factor: 2.802

9.  Limb reduction defects in endothelial nitric oxide synthase-deficient mice.

Authors:  A R Gregg; A Schauer; O Shi; Z Liu; C G Lee; W E O'Brien
Journal:  Am J Physiol       Date:  1998-12

10.  Fgf10 is essential for limb and lung formation.

Authors:  K Sekine; H Ohuchi; M Fujiwara; M Yamasaki; T Yoshizawa; T Sato; N Yagishita; D Matsui; Y Koga; N Itoh; S Kato
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

View more
  3 in total

Review 1.  The two domain hypothesis of limb prepattern and its relevance to congenital limb anomalies.

Authors:  Hirotaka Tao; Yasuhiko Kawakami; Chi-Chung Hui; Sevan Hopyan
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2017-03-20       Impact factor: 5.814

2.  Replication and exploratory analysis of 24 candidate risk polymorphisms for neural tube defects.

Authors:  Faith Pangilinan; Anne M Molloy; James L Mills; James F Troendle; Anne Parle-McDermott; Denise M Kay; Marilyn L Browne; Emily C McGrath; Hatice Ozel Abaan; Marie Sutton; Peadar N Kirke; Michele Caggana; Barry Shane; John M Scott; Lawrence C Brody
Journal:  BMC Med Genet       Date:  2014-10-08       Impact factor: 2.103

3.  Gibbon genome and the fast karyotype evolution of small apes.

Authors:  Lucia Carbone; R Alan Harris; Sante Gnerre; Krishna R Veeramah; Belen Lorente-Galdos; John Huddleston; Thomas J Meyer; Javier Herrero; Christian Roos; Bronwen Aken; Fabio Anaclerio; Nicoletta Archidiacono; Carl Baker; Daniel Barrell; Mark A Batzer; Kathryn Beal; Antoine Blancher; Craig L Bohrson; Markus Brameier; Michael S Campbell; Oronzo Capozzi; Claudio Casola; Giorgia Chiatante; Andrew Cree; Annette Damert; Pieter J de Jong; Laura Dumas; Marcos Fernandez-Callejo; Paul Flicek; Nina V Fuchs; Ivo Gut; Marta Gut; Matthew W Hahn; Jessica Hernandez-Rodriguez; LaDeana W Hillier; Robert Hubley; Bianca Ianc; Zsuzsanna Izsvák; Nina G Jablonski; Laurel M Johnstone; Anis Karimpour-Fard; Miriam K Konkel; Dennis Kostka; Nathan H Lazar; Sandra L Lee; Lora R Lewis; Yue Liu; Devin P Locke; Swapan Mallick; Fernando L Mendez; Matthieu Muffato; Lynne V Nazareth; Kimberly A Nevonen; Majesta O'Bleness; Cornelia Ochis; Duncan T Odom; Katherine S Pollard; Javier Quilez; David Reich; Mariano Rocchi; Gerald G Schumann; Stephen Searle; James M Sikela; Gabriella Skollar; Arian Smit; Kemal Sonmez; Boudewijn ten Hallers; Elizabeth Terhune; Gregg W C Thomas; Brygg Ullmer; Mario Ventura; Jerilyn A Walker; Jeffrey D Wall; Lutz Walter; Michelle C Ward; Sarah J Wheelan; Christopher W Whelan; Simon White; Larry J Wilhelm; August E Woerner; Mark Yandell; Baoli Zhu; Michael F Hammer; Tomas Marques-Bonet; Evan E Eichler; Lucinda Fulton; Catrina Fronick; Donna M Muzny; Wesley C Warren; Kim C Worley; Jeffrey Rogers; Richard K Wilson; Richard A Gibbs
Journal:  Nature       Date:  2014-09-11       Impact factor: 49.962

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.